UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000030030 |
|---|---|
| Receipt number | R000034286 |
| Scientific Title | TAS-102 and Bevacizumab as third line chemotherapy for colorectal cancer. Phase 2 trial |
| Date of disclosure of the study information | 2018/03/01 |
| Last modified on | 2019/05/21 10:10:27 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/11/18 22:49:07 | ||
| 2 | Update | 2019/05/21 10:10:27 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
